• FirefoxUpgrade to the new Firefox »
  •  Dow Down 0.79% Nasdaq Up 0.16%

    Incyte Corporation (INCY)

    -NasdaqGS
    79.90 2.29(2.95%) Jan 23, 4:00PM EST
    Add to Portfolio
    Prev Close:77.61
    Open:77.29
    Bid:77.59 x 200
    Ask:N/A
    1y Target Est:83.08
    Beta:0.25
    Earnings Date:Feb 10 - Feb 16 (Est.)
    Day's Range:76.84 - 80.00
    52wk Range:40.30 - 80.78
    Volume:1,253,872
    Avg Vol (3m):1,363,010
    Market Cap:13.50B
    P/E (ttm):N/A
    EPS (ttm):-0.33
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for INCY

    Comparison

    Symbol% ChgMkt Cap
    INCYUp 2.95%13.50B
    AMGN121.56B
    CELG98.95B
    RHHBYN/A

    Key Statistics

    Forward P/E (1 yr):380.48
    P/S (ttm):27.06
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.13
    Quarterly EPS Est (Dec-14) :-0.05
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-7.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary small molecule drugs primarily for oncology and inflammation. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback